Saturday 17 October 2026
Export ASPI’s income statement to Excel — free account
ASP Isotopes Inc.
ASPI Basic Materials Chemicals
ASP Isotopes Inc.’s revenue for fiscal 2025 (year ended December 2025) was $23.8 million, up 475.5% from fiscal 2024. In the quarter to June 2026, revenue grew 327.6%, EPS grew 73.8%, free cash flow fell 182.9% and total debt rose 162.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.14
0.07
−3.17%
Follow ASPI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
101.62 | 18.62 | 19.86 | 24.74 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(96.17) | (24.88) | (30.11) | (32.71) | |
P/B ratio |
8.82 | 1.69 | 1.79 | 2.78 | |
Price to Tangible BV |
9.62 | 1.73 | 1.83 | 2.85 | |
EV/Sales |
101.84 | 13.36 | 18.58 | 24.89 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(36.04) | (8.43) | (9.55) | (11.32) | |
EV/FCF |
(13.35) | (6.72) | (7.60) | (9.20) | |
Quick Ratio |
5.74 | 11.02 | 4.20 | 3.73 | |
Current Ratio |
6.14 | 12.23 | 4.39 | 3.87 | |
Net Debt/EBITDA |
(0.13) | 5.20 | 1.59 | (0.14) | |
Debt/Assets |
51.28% | 40.53% | 44.01% | 46.06% | |
Debt/Equity |
1.20 | 0.77 | 0.86 | 0.96 | |
Asset Turnover |
0.05 | 0.08 | 0.08 | 0.09 | |
Operating CF/Net income |
0.69 | 0.23 | 2.58 | 0.69 | |
Capex/Depreciation |
(100.60) | 30.55 | (2.01) | (3.30) | |
Interest Coverage |
(102.44) | (96.27) | (14.39) | (19.28) | |
Research and Development Expense of Revenue |
63.37% | 41.11% | 125.91% | 133.20% | |
Selling, General and Administrative Expense of Revenue |
251.39% | 105.26% | 509.35% | 563.17% | |
Intangible Assets out of Total Assets |
0.04 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
91.71% | 35.38% | 105.55% | 88.66% | |
Graham Net Nets |
0.05 | 0.37 | 0.04 | (0.03) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(14.86%) | (40.00%) | (47.06%) | (21.22%) | |
Free Cash Flow Yield |
(7.51%) | (10.68%) | (12.30%) | (10.93%) | |
Revenue per Share |
0.06 | 0.20 | 0.03 | 0.04 | |
Operating CF per Share |
(0.10) | (0.21) | (0.15) | (0.19) | |
Capex per Share |
(0.37) | 0.33 | (0.05) | (0.03) | |
Free Cash Flow per Share |
(0.47) | 0.12 | (0.20) | (0.22) | |
Cash per Share |
1.29 | 3.94 | 2.42 | 2.11 | |
Shareholders Equity per Share |
1.09 | 3.17 | 2.47 | 2.24 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.09 | 3.17 | 2.47 | 2.24 | |
Free Cash Flow |
(42.01) | 9.75 | (23.90) | (27.30) | |
Working Capital |
145.72 | 367.22 | 238.37 | 201.89 | |
Capital Expenditures |
(33.15) | 27.60 | (6.14) | (3.97) | |
Net Current Asset Value |
44.76 | 164.80 | 20.09 | (25.09) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
6.78 | (1.66) | 1.47 | 0.77 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
24.60 | 16.91 | 1.54 | 17.04 | |
Average Payables |
2.61 | 2.42 | 4.46 | 4.15 | |
Average Inventory |
0.73 | 0.58 | 0.86 | 1.29 | |
Average Assets |
155.01 | 296.18 | 339.27 | 353.98 | |
Average Common Equity |
69.31 | 157.03 | 172.37 | 151.55 |
Columns are period end dates